ARTICLE IN ACADEMIC JOURNALS
NO | DETAILS OF ARTICLE IN ACADEMIC JOURNALS |
---|---|
1. |
Antidepressant decision aid for major depressive disorder patients (ADAM): Development and pilot testing
2022
Author(s) : Ahmad Hatim Bin Sulaiman,Hasniza Binti Zaman Huri Source : PATIENT EDUCATION AND COUNSELING DOI : 10.1016/j.pec.2021.11.007 |
2. |
Psychiatric pharmaceutical care service across Malaysian hospitals: results from a cross-sectional study
2022
Source : BMC health services research DOI : 10.1186/s12913-022-07681-4 |
3. |
Pharmacokinetic–Pharmacometabolomic Approach in Early-Phase Clinical Trials: A Way Forward for Targeted Therapy in Type 2 Diabetes
2022
Source : Pharmaceutics DOI : 10.3390/pharmaceutics14061268 |
4. |
Targeted Primary and Secondary Preventive Strategies for Depression among Malaysian Pharmacy Students
2022
Author(s) : Hasniza Binti Zaman Huri,Izyan Binti A Wahab Source : INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH DOI : 10.3390/ijerph19159629 |
5. |
Pharmacokinetics and Metabolomic Profiling of Metformin and Andrographis paniculata: A Protocol for a Crossover Randomised Controlled Trial
2022
Source : Journal of Clinical Medicine DOI : 10.3390/jcm11143931 |
6. |
Antidepressant decision aid for major depressive disorder patients (ADAM): Development and pilot testing
2022
Author(s) : Ahmad Hatim Bin Sulaiman,Hasniza Binti Zaman Huri Source : Patient Education and Counseling DOI : 10.1016/j.pec.2021.11.007 |
7. |
Pharmacokinetic-Pharmacometabolomic Approach in Early-Phase Clinical Trials: A Way Forward for Targeted Therapy in Type 2 Diabetes
2022
Source : PHARMACEUTICS DOI : 10.3390/pharmaceutics14061268 |
8. |
Pharmacokinetics and Metabolomic Profiling of Metformin and Andrographis paniculata: A Protocol for a Crossover Randomised Controlled Trial
2022
Source : JOURNAL OF CLINICAL MEDICINE DOI : 10.3390/jcm11143931 |
9. |
Psychiatric pharmaceutical care service across Malaysian hospitals: results from a cross-sectional study
2022
Source : BMC HEALTH SERVICES RESEARCH DOI : 10.1186/s12913-022-07681-4 |
10. |
Targeted Primary and Secondary Preventive Strategies for Depression among Malaysian Pharmacy Students
2022
Author(s) : Hasniza Binti Zaman Huri,Izyan Binti A Wahab Source : International journal of environmental research and public health DOI : 10.3390/ijerph19159629 |
11. |
Medication Adherence for Haemophilia Patients: Outcome of Prophylaxis Treatment Intervention
2021
Author(s) : Hasniza Binti Zaman Huri Source : HEALTHCARE DOI : 10.3390/healthcare9121702 |
12. |
Association of YKL-40 Encoding Gene CHI3L1 rs946263 with Insulin Resistance and Severity of Coronary Artery Disease in Type 2 Diabetes Mellitus Patients
2021
Author(s) : Hasniza Binti Zaman Huri Source : METABOLISM-CLINICAL AND EXPERIMENTAL DOI : 10.1016/j.metabol.2020.154520 |
13. |
A Clinical Practice Guideline Summary for Pharmacological Management of Adults with Major Depressive Disorder in Malaysia
2021
Author(s) : Hasniza Binti Zaman Huri,Ng Chong Guan Source : JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL DOI : 10.9734/JPRI/2021/v33i45B32821 |
14. |
Pharmacogenetics of sulfonylurea-induced hypoglycemia in Type 2 diabetes patients: the SUCLINGEN study
2021
Author(s) : Hasniza Binti Zaman Huri Source : PHARMACOGENOMICS DOI : 10.2217/pgs-2021-0059 |
15. |
Pharmacometabolomics of Meformin Demonstrated Insulin Sensitivity Related Pathways at Peak Plasma Concentration on Healthy Volunteers - Preliminary Results
2021
Source : METABOLISM-CLINICAL AND EXPERIMENTAL DOI : 10.1016/j.metabol.2020.154536 |
16. |
Single Nucleotide Polymorphism rs17173608 in the Chemerin Encoding Gene: Is It a Predictor of Insulin Resistance and Severity of Coronary Artery Disease in Non-Obese Type 2 Diabetes?
2021
Author(s) : Wan Azman Bin Wan Ahmad,Hasniza Binti Zaman Huri Source : HEALTHCARE DOI : 10.3390/healthcare9060623 |
17. |
Retinol-Binding Protein-4-A Predictor of Insulin Resistance and the Severity of Coronary Artery Disease in Type 2 Diabetes Patients with Coronary Artery Disease
2021
Author(s) : Wan Azman Bin Wan Ahmad,Hasniza Binti Zaman Huri Source : BIOLOGY-BASEL DOI : 10.3390/biology10090858 |
18. |
Associations between Socio-Demographic Factors and Hypertension Management during the COVID-19 Pandemic: Preliminary Findings from Malaysia
2021
Author(s) : Hasniza Binti Zaman Huri Source : INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH DOI : 10.3390/ijerph18179306 |
19. |
Patient-Centred Communication in the Use of Antidepressants among People with Depression: A Scoping Review
2021
Author(s) : Ahmad Hatim Bin Sulaiman,Jesjeet Singh Gill A/l Jeswant Singh,Hasniza Binti Zaman Huri,Koh Ong Hui,Ng Chong Guan,Fatin Liyana Binti Azhar,Benedict Francis Source : SAINS MALAYSIANA DOI : 10.17576/jsm-2021-5001-16 |
20. |
Clinical and genetic predictors of secondary sulfonylurea failure in Type 2 diabetes patients: the SUCLINGEN study
2020
Source : PHARMACOGENOMICS DOI : 10.2217/pgs-2019-0171 |
21. |
Heart Failure With Type 2 Diabetes Mellitus: Association Between Antihyperglycemic Agents, Glycemic Control, and Ejection Fraction
2020
Author(s) : Hasniza Binti Zaman Huri,Chee Kok Han Source : FRONTIERS IN ENDOCRINOLOGY DOI : 10.3389/fendo.2020.00448 |
22. |
Global Scope of Hospital Pharmacy Practice: A Scoping Review
2020
Source : HEALTHCARE DOI : 10.3390/healthcare8020143 |
23. |
Heart Failure with Type 2 Diabetes Mellitus: Association between Antihyperglycemic Agents, Glycemic Control, and Ejection Fraction
2020
Author(s) : Hasniza Binti Zaman Huri,Chee Kok Han Source : Frontiers in Endocrinology |
24. |
Clinical and genetic markers of erythropoietin deficiency anemia in chronic kidney disease (predialysis) patients
2020
Author(s) : Hasniza Binti Zaman Huri,Lim Soo Kun Source : BIOMARKERS IN MEDICINE DOI : 10.2217/bmm-2020-0205 |
25. |
Clinical and genetic predictors of secondary sulfonylurea failure in type 2 diabetes patients: The SUCLINGEN study
2020
Source : Pharmacogenomics |
26. |
Clinical and Genetic Marker of Erythropoietin Deficiency Anaemia in Chronic Kidney Disease (pre-dialysis) Patients
2020
Author(s) : Hasniza Binti Zaman Huri Source : Biomarkers in Medicine |
27. |
GLOBAL SCOPE OF HOSPITAL PHARMACY PRACTICE: A SCOPING REVIEW
2020
Author(s) : Hasniza Binti Zaman Huri Source : Healthcare |
28. |
Pharmacist-led Academic Detailing Improves Statin Therapy Prescribing for Malaysian Patients with Type 2 Diabetes: Quasi-Experimental Design
2019
Author(s) : Hasniza Binti Zaman Huri Source : Plos One |
29. |
Pharmacist-led Academic Detailing Improves Statin Therapy Prescribing for Malaysian Patients with Type 2 Diabetes: Quasi-Experimental Design.
2019
Author(s) : Hasniza Binti Zaman Huri Source : Plos One |
30. |
Drug-related problems in patients with rheumatoid arthritis
2019
Author(s) : Hasniza Binti Zaman Huri Source : THERAPEUTICS AND CLINICAL RISK MANAGEMENT |
31. |
Effectiveness and prescription pattern of lipid-lowering therapy and its associated factors among patients with type 2 diabetes mellitus in Malaysian primary care settings
2019
Author(s) : Hasniza Binti Zaman Huri Source : THERAPEUTICS AND CLINICAL RISK MANAGEMENT |
32. |
Drug-related problems in patients with rheumatoid arthritis
2019
Author(s) : Hasniza Binti Zaman Huri,Fariz Bin Yahya Source : THERAPEUTICS AND CLINICAL RISK MANAGEMENT |
33. |
Drug Related Problems in Patients with Rheumatoid Arthritis
2019
Author(s) : Hasniza Binti Zaman Huri Source : Therapeutic and Clinical Risk Management |
34. |
Pharmacist-led academic detailing improves statin therapy prescribing for Malaysian patients with type 2 diabetes: Quasi-experimental design
2019
Author(s) : Hasniza Binti Zaman Huri Source : PLOS ONE |
35. |
Effectiveness and prescription pattern of lipid-lowering therapy and its associated factors among patients with type 2 diabetes mellitus in Malaysian primary care settings
2019
Author(s) : Hasniza Binti Zaman Huri Source : Therapeutic and Clinical Risk Management |
36. |
Reduced mitochondrial DNA content in lymphocytes is associated with insulin resistance and inflammation in patients with impaired fasting glucose
2018
Author(s) : Hasniza Binti Zaman Huri Source : Clinical and Experimental Medicine |
37. |
Development of a strategic tool for shared decision-making in the use of antidepressants among patients with major depressive disorder
2018
Author(s) : Hasniza Binti Zaman Huri Source : IJERPH |
38. |
The Use of Antidepressants for Physical and Psychological Symptoms in Cancer
2018
Author(s) : Ahmad Hatim Bin Sulaiman,Hasniza Binti Zaman Huri Source : Current Dr |
39. |
Association of glycaemic control and progression of diabetic retinopathy in type 2 diabetes mellitus patients
2018
Author(s) : Hasniza Binti Zaman Huri Source : Brazilian Journal of Pharmaceutical Sciences |
40. |
Glycemic effects of simvastatin: Where do we stand?
2018
Author(s) : Hasniza Binti Zaman Huri,Luqman Bin Ibrahim Source : Brazilian Journal of Pharmaceutical Sciences |
41. |
Attitude and Self-Medication practice on Antibiotic use amongst general public in Alor Setar, Kedah, Malaysia
2018
Author(s) : Hasniza Binti Zaman Huri Source : Madridge J Pharm Res |
42. |
Impact of Educational Outreach Intervention on Enhancing Healthcare Providers Knowledge about Statin Therapy Prescribing in Malaysian Patients with Type 2 Diabetes Mellitus
2018
Author(s) : Hasniza Binti Zaman Huri Source : Journal of Evaluation in Clinical Practice |
43. |
Reduced mitochondrial DNA content in lymphocytes is associated with insulin resistance and inflammation in patients with impaired fasting glucose
2018
Author(s) : Hasniza Binti Zaman Huri Source : CLINICAL AND EXPERIMENTAL MEDICINE |
44. |
Patterns of statin therapy prescribing among hospitalized patients with Type 2 diabetes mellitus in two Malaysian tertiary hospitals
2018
Author(s) : Hasniza Binti Zaman Huri Source : Tropical Journal of Pharmaceutical Research |
45. |
Demographic, Clinical and Lifestyle Predictors for Severity of Erectile Dysfunction and Biomarkers level in Malaysian Patients
2018
Author(s) : Hasniza Binti Zaman Huri Source : Brazilian Journal of Pharmaceutical Sciences |
46. |
Statin therapy prescribing for patients with type 2 diabetes mellitus: A review of current evidence and challenges.
2017
Author(s) : Hasniza Binti Zaman Huri Source : J Pharm Bioall Sci |
47. |
Drug-related problems in patients with erectile dysfunctions and multiple co-morbidities
2017
Author(s) : Hasniza Binti Zaman Huri Source : Therapeutics and Clinical Risk Management |
48. |
Altered Circulating Concentrations Of Active Glucagon-Like Peptide (GLP-1) And Dipeptidyl Peptidase 4 (DPP4) In Obese Subjects And Their Association With Insulin Resistance
2017
Author(s) : Hasniza Binti Zaman Huri Source : Clinical Biochemistry |
49. |
A Review of The Use of Mirtazapine in Cancer Patients
2017
Author(s) : Hasniza Binti Zaman Huri Source : Malaysian Journal of Psychiatry |
50. |
Apoptotic induction and inhibition of NF- B signaling pathway in human prostatic cancer PC3 cells by natural compound 2,2 -oxybis (4-allyl-1-methoxybenzene), biseugenol B, from Litsea costalis : an in vitro study.
2017
Author(s) : Hasniza Binti Zaman Huri Source : OncoTargets |
51. |
Alterations of cultured myotubes and fasting plasma metabolite profiles related to mitochondrial dysfunction in Type 2 diabetes subjects
2017
Author(s) : Hasniza Binti Zaman Huri Source : Free Radical Biology and Medicine |
52. |
Chemokine like receptor- 1 (CMKLR-1) receptor: A Potential Therapeutic Target in Management of Chemerin Induced Type 2 Diabetes Mellitus and Cancer
2017
Source : Current Pharmaceutical Design |
53. |
Association of psychological factors, patients knowledge, and management among patients with erectile dysfunction
2016
Author(s) : Hasniza Binti Zaman Huri Source : Patient Preference and Adherence |
54. |
Association of rs5219 KCNJ11 Gene Polymorphism with Pancreatic Beta-Cell Function, Insulin Resistance, and Glycemic Control of Sulfonylurea-treated Malaysian Type 2 Diabetes Patients.
2016
Author(s) : Hasniza Binti Zaman Huri Source : Diabetes |
55. |
A Study on Cloning and Expression of HIV A Study on Cloning and Expression of HIVA Study on Cloning and Expression of HIV by Transient Transfection
2016
Author(s) : Hasniza Binti Zaman Huri Source : Research Journal of Pharmaceutical, Biological and Chemical Sciences |
56. |
Factors Associated with Hypoglycemia Episodes In Hospitalised Type 2 Diabetes Mellitus Patients
2016
Author(s) : Hasniza Binti Zaman Huri Source : Tropical Journal of Pharmaceutical Research |
57. |
Clinical and genetic predictors of dipeptidyl peptidase-4 inhibitor treatment response in type 2 diabetes mellitus
2016
Author(s) : Hasniza Binti Zaman Huri Source : Pharmacogenomics |
58. |
Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells.
2016
Author(s) : Hasniza Binti Zaman Huri Source : Drug Design Development and Therapy |
59. |
Apoptotic induction and inhibition of NF- B signaling pathway in human prostatic cancer PC3 cells by natural Compound 2,2'-Oxybis (4-allyl-1-methoxybenzene), biseugenol B, from Litsea Costalis: an in vitro study
2016
Author(s) : Hasniza Binti Zaman Huri Source : OncoTargets and Therapy |
60. |
Association of DPP4 Gene Polymorphisms with Type 2 Diabetes Mellitus in Malaysian subjects
2016
Author(s) : Hasniza Binti Zaman Huri Source : PLoS One |
61. |
Genetic markers predicting sulphonylurea treatment outcomes in Type 2 Diabetes patients: current evidence and challenges for clinical implementation
2016
Author(s) : Hasniza Binti Zaman Huri Source : The Pharmacogenomics Journal |
62. |
Genetic Polymorphisms Associated with Overweight and Obesity in Uncontrolled Type 2 Diabetes Mellitus.
2016
Author(s) : Hasniza Binti Zaman Huri Source : Biomarkers in Medicine |
63. |
Potential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand?
2016
Author(s) : Hasniza Binti Zaman Huri Source : Cell Death Disease |
64. |
Polyesters Based on Linoleic Acid for Biolubricant Basestocks: Low Temperature,Tribological and Rheological Properties.
2016
Author(s) : Hasniza Binti Zaman Huri Source : Plos One |
65. |
Association of Genetic Polymorphisms of Dipeptidyl Peptidase-4 with Metabolic Syndrome Parameters in Malaysian Subjects. Public Health Genomics
2015
Author(s) : Hasniza Binti Zaman Huri Source : Public Health Genomics |
66. |
Association between glycemic control and anti-diabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications
2015
Author(s) : Hasniza Binti Zaman Huri Source : Drug Design Development and Therapy |
67. |
Glycaemic Control and Antidiabetic Drugs in Type 2 Diabetes Mellitus Patients with Renal Complications
2015
Author(s) : Hasniza Binti Zaman Huri Source : Drug Design Development and Therapy |
68. |
The Serum Level of Soluble CD26/Dipeptidyl Peptidase-IV in Type 2 Diabetes Mellitus and Its Association with Metabolic Syndrome and Therapy with Antidiabetic Agents in Malaysian Subjects
2015
Author(s) : Hasniza Binti Zaman Huri Source : PLoS One |
69. |
Glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with renal complications.
2015
Source : Drug design, development and therapy |
70. |
Chronic Kidney Disease Screening Methods and Its Implication for Malaysia: An in Depth Review
2015
Author(s) : Hasniza Binti Zaman Huri Source : Global Journal of Health Science |
71. |
Antitumor Activity for Gold (III) Complex by High Content Screening Technique (HCS) and Cell Viability Assay
2015
Author(s) : Hasniza Binti Zaman Huri Source : Asian Journal of Biochemistry |
72. |
Metabolomics The Complementary Field in Systems Biology: A Review on Obesity and Type 2 Diabetes
2015
Author(s) : Hasniza Binti Zaman Huri Source : Molecular Biosystems |
73. |
JNK Signaling Pathways Is Required For Mitochondrial Dysfunction-Induced Insulin Resistance In WRL-68 Human Liver Cell
2015
Author(s) : Hasniza Binti Zaman Huri Source : Diabetes Technology & Therapeutics |
74. |
Celastrol Protects Against Antimycin A-induced Insulin Resistance in Human Skeletal Muscle Cells
2015
Author(s) : Hasniza Binti Zaman Huri Source : Molecules |
75. |
A Review on Biologically Active N-Myristoylated HIV-1 Nef Protein
2015
Author(s) : Hasniza Binti Zaman Huri Source : Asian Journal of Biochemistry |
76. |
Mitochondrial Dysfunction as a Central Event for Mechanisms Underlying Insulin Resistance: The Roles of Long Chain Fatty Acids
2015
Author(s) : Hasniza Binti Zaman Huri Source : Diabetes/Metabolism Research and Reviews |
77. |
Pathway Mechanism of Potential Genomic Markers of Dipeptidyl Peptidase-4 Inhibitor Treatment Response in Type 2 Diabetes
2015
Author(s) : Hasniza Binti Zaman Huri Source : Public Health Genomics |
78. |
Impact of Single Nucleotide Polymorphisms(SNPs) of Type 2 Diabetes (T2D) Genes on Patients Response to Sulphonylurea Therapy
2015
Author(s) : Hasniza Binti Zaman Huri Source : Public Health Genomics |
79. |
Metabolomics - the complementary field in systems biology: a review on obesity and type 2 diabetes
2015
Author(s) : Hasniza Binti Zaman Huri Source : MOLECULAR BIOSYSTEMS |
80. |
Potential biomarkers for insulin resistance and atherosclerosis among type 2 diabetes mellitus patients with coronary artery disease
2014
|
81. |
Drug-Related Problems in Patients with Benign Prostatic Hyperplasia: A Cross Sectional Retrospective Study
2014
Author(s) : Hasniza Binti Zaman Huri Source : Plos One |
82. |
Pancreatic gene variants potentially associated with dipeptidyl peptidase-4 inhibitor treatment response in Type 2 Diabetes
2014
Author(s) : Hasniza Binti Zaman Huri Source : Pharmacogenomics |
83. |
Factors Associated With Treatment Response To Antidiabetic Agents In Compliant Type 2 Diabetes Mellitus Patients: A Brief Summary Of 5 Years'Data
2014
Author(s) : Hasniza Binti Zaman Huri |
84. |
Pancreatic gene variants potentially associated with dipeptidyl peptidase-4 inhibitor treatment response in Type 2 diabetes
2014
Author(s) : Hasniza Binti Zaman Huri Source : Pharmacogenomics |
85. |
A Prospective Cohort Study of IRS Genes Polymorphisms in Type 2 Diabetes Mellitus Patients during Severe/Acute Hyperglycemia Phase: Part 2: Association with Glycemic Control.
2014
Author(s) : Hasniza Binti Zaman Huri |
86. |
Amelioration of Mitochondrial Dysfunction-induced Insulin Resistance in Differentiated 3T3-L1 Adipocytes via Inhibition of NF-κB Pathways
2014
Author(s) : Hasniza Binti Zaman Huri Source : International Journal of Molecular Sciences |
87. |
Sliding-Scale versus Basal-Bolus Insulin in the Management of Severe or Acute Hyperglycemia in Type 2 Diabetes Patients: A Retrospective Study
2014
Source : Plos One |
88. |
Pancreatic gene variants potentially associated with dipeptidyl peptidase-4 inhibitor treatment response in Type 2 diabetes
2014
Source : Pharmacogenomics |
89. |
Drug-Related Problems in Patients with Benign Prostatic Hyperplasia: A Cross Sectional Retrospective Study
2014
Author(s) : Hasniza Binti Zaman Huri Source : Plos One |
90. |
Factors Associated with Treatment Response to Antidiabetic Agents in Compliant Type 2 Diabetes Mellitus Patients: A Brief Summary of 5-Year Data
2014
Author(s) : Hasniza Binti Zaman Huri Source : Tropical Journal of Pharmaceutical Research |
91. |
Effect of Interaction between Polymorphisms in the Insulin Receptor Substrate Genes in Type 2 Diabetes Mellitus Patients with Severe/Acute Hyperglycemia.
2014
Author(s) : Hasniza Binti Zaman Huri |
92. |
Amelioration of Mitochondrial Dysfunction-Induced Insulin Resistance in Differentiated 3T3-L1 Adipocytes via Inhibition of NF-kappa B Pathways
2014
Author(s) : Hasniza Binti Zaman Huri Source : International Journal of Molecular Sciences |
93. |
Drug-Related Problems in Patients with Benign Prostatic Hyperplasia: A Cross Sectional Retrospective Study
2014
Author(s) : Hasniza Binti Zaman Huri Source : PLOS ONE |
94. |
A Prospective Cohort Study of IRS Genes Polymorphisms in Type 2 Diabetes Mellitus Patients during Severe/Acute Hyperglycemia Phase: Part 1: Association with Insulin Resistance
2014
Author(s) : Hasniza Binti Zaman Huri Source : Tropical Journal of Pharmaceutical Research |
95. |
Studies of the impact of occupational exposure on pharmaceutical workers to the development of antimicrobial drug resistance.
2014
Author(s) : Hasniza Binti Zaman Huri |
96. |
Palm Olein as Renewable Raw Materials for Industrial and Pharmaceutical Products Applications: Chemical Characterization and Physicochemical Properties Studies
2014
Author(s) : Hasniza Binti Zaman Huri Source : Advances in Materials Science and Engineering |
97. |
Oral drug treatments in patients with erectile dysfunction and multiple comorbidities: a retrospective observational study
2014
Author(s) : Azad Hassan Bin Abdul Razack,Hasniza Binti Zaman Huri Source : Bmj Open |
98. |
Studies of the Impact of Occupational Exposure of Pharmaceutical Workers on the Development of Antimicrobial Drug Resistance
2014
Author(s) : Hasniza Binti Zaman Huri Source : Journal of Occupational Health |
99. |
Factors Associated with Utilization of Dipeptidyl- 4 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Cross-sectional Retrospective Study
2014
Author(s) : Hasniza Binti Zaman Huri Source : International Journal of Endocrinology |
100. |
Oral Drug Treatments in Subjects with Erectile Dysfunction and Multiple Comorbidities
2014
Author(s) : Rozalina Binti Zakaria,Sulaiman Wadi Harun Source : Bmj Open |
101. |
Sliding-scale versus basal-bolus insulin in the management of severe or acute hyperglycemia in type 2 diabetes patients: A retrospective study.
2014
Author(s) : Hasniza Binti Zaman Huri Source : Plos One |
102. |
Management of severe/acute hyperglycemia in hospitalised type 2 diabetes mellitus patients
2013
Author(s) : Hasniza Binti Zaman Huri |
103. |
Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study
2013
Author(s) : Hasniza Binti Zaman Huri Source : Bmc Endocrine Disorders |
104. |
Potential biomarkers of insulin resistance and atherosclerosis in type 2 diabetes mellitus patients with coronary artery disease
2013
Author(s) : Hasniza Binti Zaman Huri |
105. |
Drug-Related Problems in Type 2 Diabetes Mellitus Patients with Dyslipidemia.
2013
Author(s) : Hasniza Binti Zaman Huri Source : BMC Public Health |
106. |
Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study
2013
Author(s) : Hasniza Binti Zaman Huri Source : Bmc Endocrine Disorders |
107. |
Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia
2013
Author(s) : Hasniza Binti Zaman Huri Source : Bmc Public Health |
108. |
Demographic and Clinical Predictors for Insulin Resistance in Type 2 Diabetes Mellitus Patients During Severe/Acute Hyperglycemia Phase.
2013
Author(s) : Hasniza Binti Zaman Huri |
109. |
Drug Related Problems in Type 2 Diabetes Patients
With
Hypertension: A Cross-Sectional Retrospective
Study.
2013
Author(s) : Hasniza Binti Zaman Huri Source : BMC Endocrine Disorders |
110. |
Optimisation of glycaemic control during episodes
of
severe/acute hyperglycaemia in patients with type
2
diabetes mellitus.
2012
Author(s) : Hasniza Binti Zaman Huri Source : International Journal of Clinical Pharmacy |
111. |
Demographic and Clinical Predictors for Insulin Resistance in Type 2 Diabetes Mellitus Patients During Severe/Acute Hyperglycemia Phase.
2012
Author(s) : Hasniza Binti Zaman Huri |
112. |
Factors influencing utilization of different types of sulphonylureas amongst type 2 diabetes patients
2010
Source : Latin American Journal of Pharmacy |
113. |
Factors influencing prescribing of different types of sulphonylureas amongst type 2 diabetes patients.
2010
Author(s) : Hasniza Binti Zaman Huri |
114. |
Factors Influencing Utilization of Different Types of Sulphonylureas Amongst Type 2 Diabetes Patients
2010
Source : Latin American Journal of Pharmacy |
115. |
A survey amongst Complementary Alternative Medicine (CAM) users with type 2 diabetes
2009
Author(s) : Rokiah Binti Pendek,Riyanto Teguh Widodo,Samsinah Binti Hussain,Hasniza Binti Zaman Huri Source : International Journal of Diabetes and Metabolism |
116. |
Different characteristics of diabetic ketoacidosis between type 1 and type 2 diabetes patients in Malaysia
2009
Source : Asian Biomedicine |
117. |
A survey amongst Complementary Alternative Medicine (CAM) users with type 2 diabetes.
2009
Author(s) : Hasniza Binti Zaman Huri |
118. |
Comparison of diabetic ketoacidosis between type I and type II diabetics in Malaysia
2009
Author(s) : Hasniza Binti Zaman Huri |
119. |
Use of antiplatelet agents for primary and secondary prevention of cardiovascular disease amongst type 2 diabetic patients
2008
Author(s) : Rokiah Binti Pendek,Hasniza Binti Zaman Huri Source : Journal of Pharmacy Practice |
120. |
Utilization of antiplatelet agents for primary and secondary prevention of cardiovascular disease amongst type 2 diabetics.
2008
Author(s) : Hasniza Binti Zaman Huri Source : Journal of Pharmacy Practice |
121. |
Self-Monitoring Blood Glucose (SMBG) in type 2 diabetics in Malaysia
2008
Author(s) : Hasniza Binti Zaman Huri |
122. |
Self-monitoring of blood glucose among type-2 diabetes patients in Malaysia
2008
Author(s) : Rokiah Binti Pendek,Hasniza Binti Zaman Huri Source : Asian Biomedicine |
123. |
Episodes of hypoglycemia and hyperglycemia during the use of sliding scale insulin in hospitalized diabetes patients
2007
Author(s) : Hasniza Binti Zaman Huri Source : Asian Biomedicine |
BOOK
NO | DETAILS OF BOOK |
---|---|
1. |
Utilisation of Variable Rate Intravenous Insulin Infusion
2017
Author(s) : Hasniza Binti Zaman Huri,Luqman Bin Ibrahim |
2. |
Biolubricant Base Oil Synthesis and Its Application: Pharmaceutical and Industrial Applications Based on Enviromental Friendly
2015
Author(s) : Hasniza Binti Zaman Huri |
3. |
Hydrolysis, Separation and Purification of Fatty Acids for Bioproducts
2015
Author(s) : Hasniza Binti Zaman Huri |
4. |
Training Manual for
Pharmacists for Management of Obesity and Overweight.
2012
Author(s) : Hasniza Binti Zaman Huri |
CHAPTER IN BOOK
NO | DETAILS OF CHAPTER IN BOOK |
---|---|
1. |
Dyslipidemia and Type 2 Diabetes Mellitus: Implications
and Role of Antiplatelet Agents in Primary Prevention
of Cardiovascular Disease
2012
Author(s) : Hasniza Binti Zaman Huri |
2. |
Dyslipidemia and type 2 diabetes mellitus:
Implications and role of antiplatelet agents in
primary prevention of cardiovascular diseases.
2011
Author(s) : Hasniza Binti Zaman Huri |
PROCEEDING
NO | DETAILS OF PROCEEDING |
---|---|
1. |
Pharmacy Programme and Clinical Pharmacy Teaching in the University of Malaya
2006
Author(s) : Hasniza Binti Zaman Huri |
EXTENDED ABSTRACT
NO | DETAILS OF EXTENDED ABSTRACT |
---|---|
1. |
Pharmacometabolomics of Meformin Demonstrated Insulin Sensitivity Related Pathways at Peak Plasma Concentration on Healthy Volunteers Preliminary Results
2021
Author(s) : Hasniza Binti Zaman Huri |
2. |
Association of YKL-40 Encoding Gene CHI3L1 rs946263 with Insulin Resistance and Severity of Coronary Artery Disease in Type 2 Diabetes Mellitus Patients
2021
Author(s) : Hasniza Binti Zaman Huri |
3. |
Association of rs5219 KCNJ11 Gene Polymorphism with Pancreatic Beta-Cell Function, Insulin Resistance, and Glycemic Control of Sulfonylurea-treated Malaysian Type 2 Diabetes Patients. Diabetes (American Diabetes Association) 2016: A428
2016
Author(s) : Hasniza Binti Zaman Huri Source : Dia |
4. |
Association Between Pancreatic Beta Cell Function and Glycemic Control of Type 2 Diabetes Patients on Maximal Sulphonylurea Therapy.
2015
Author(s) : Hasniza Binti Zaman Huri Source : Journal of Asean Federation of Endocrine Societies |
5. |
Compound 2,2'-Oxybis (4-allyl-1-methoxybenzene), biseugenol B, from Litsea Costalis induces apoptosis through activation of intrinsic, extrinsic and NF-κB signaling pathways on human prostate cancer PC3 cells in vitro
2015
Author(s) : Hasniza Binti Zaman Huri Source : Malaysian Journal of Pharmacy |
6. |
The association of WFS1 gene polymorphisms with the DPP-4 inhibitors treatment response in type 2 diabetes
2015
Author(s) : Hasniza Binti Zaman Huri |
7. |
Predictors for type 2 diabetes mellitus during
severe/acute hyperglycemic phase
2012
Author(s) : Hasniza Binti Zaman Huri |
8. |
Optimizing glycemic control during severe/acute
hyperglycemic phase in type 2 diabetes patients: From
predictors to a new approach.
2011
Author(s) : Hasniza Binti Zaman Huri |
9. |
Saliva Stimulating tablets
2008
Author(s) : Riyanto Teguh Widodo,Hasniza Binti Zaman Huri Source : Abstract book: 17th International Invention Innovation Industrial Design & Technology Exhibition 2008, KL-Malaysia 19-21 May 2008. |
10. |
Multipurpose liquid artificial saliva
formulations.
2007
Author(s) : Hasniza Binti Zaman Huri |
11. |
Congress of Asean Federation of Endocrine Societies
2007
Author(s) : Hasniza Binti Zaman Huri |
STANDARD
NO | DETAILS OF STANDARD |
---|---|
1. |
Determinants of serum vitamin D and
its metabolites and the reflection on
vitamin D status in postmenopausal
women: A systematic review
2022
Author(s) : Hasniza Binti Zaman Huri |
MASS MEDIA(NEWSPAPER,RADIO,TV,POPULAR MAGAZINE)
NO | DETAILS OF MASS MEDIA(NEWSPAPER,RADIO,TV,POPULAR MAGAZINE) |
---|---|
1. |
Management of the Diabetic Foot
2014
Author(s) : Hasniza Binti Zaman Huri |
2. |
Managing Benign Prostatic Hyperplasia
2013
Author(s) : Hasniza Binti Zaman Huri |
3. |
Managing Erectile Dysfunction
2013
Author(s) : Hasniza Binti Zaman Huri |
OTHERS
NO | DETAILS OF OTHERS |
---|---|
1. |
Effectiveness of mRNA and recombinant adenovirus vector vaccine against different variants of COVID-19: a systematic review and meta-analysis. PROSPERO 2021 CRD42021269369 Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021269369
2021
Author(s) : Hasniza Binti Zaman Huri |
RESEARCH PROJECT
GRANT | PROGRESS | STATUS |
---|---|---|
Pharmacokinetics-pharmacometabolomics Profiling Of Registered Andographis Paniculata
(KW PNC(JIM)) |
|
new |
Effect Of Slc22a1 Gene Polymorphisms On Glycemic Control And Metformin Intolerance In Type 2 Diabetes Patients At St Paul's Hospital And Zewuditu Memorial Hospital, Addis Ababa, Ethiopia
(International Funding) |
|
on going |
A Phase 1 Clinical Trial On Healthy Volunteers To Assess The Clinical Safety Of Andrographis Paniculata
(Others MOHE - Top 100 (IIRG)-FNW) |
|
end |
A Phase 1 Clinical Trial On Healthy Volunteers To Assess The Clinical Safety Of Andrographis Paniculata
Researcher(s) : Tee Khim Boon
(Others MOHE - Top 100 (IIRG)-FNW) |
|
end |
Pharmacokinetics Profile Of Andrographis Paniculata In Healthy Volunteer
Researcher(s) : Associate Prof. Dr. Alexander Tan Tong Boon,Associate Prof. Dr. Najihah Binti Mohd Hashim,Zaril Harza Zakaria,David Wishart
(Others MOHE - Top 100 (IIRG)-FNW) |
|
end |
Genetic Polymorphisms Associated With Insulin Resistance And Atherosclerosis In Type 2 Diabetes Mellitus Patients With Coronary Artery Disease.
Researcher(s) : -
(Postgraduate Research Grant (PPP) - Research) |
|
end |
Association Of Clinical And Genetic Markers With Erythropoietin Deficiency Anemia And Erythropoietin Stimulating Agents Treatment Response In Pre-dialysis Chronic Kidney Disease
Researcher(s) : Prof. Dr. Lim Soo Kun
(Fundamental Research Grant Scheme (FRGS)) |
|
end |
Clinical And Genetic Predictors For Sulphonylurea Response In Malaysian Type 2 Diabeted Patients
(Geran Penyelidikan Universiti Malaya (UMRG Programme) - HTM (Wellness)) |
|
end |
CLINICAL AND GENETIC PREDICTORS FOR SULPHONYLUREA RESPONSE IN MALAYSIAN TYPE 2 DIABETES PATIENTS
Researcher(s) : -
(Postgraduate Research Grant (PPP) - Research) |
|
end |
Targeting The Human Prostate Cancer Stem Cells (pc3) Using Natural Compound From Litsea Costalis: A Novel Strategy To Overcome The Drug Resistant Aggresive Breast Tumors
Researcher(s) : -
(Postgraduate Research Grant (PPP) - Research) |
|
end |
Genetic Markers Of Oral Incretin-Based Therapy Response In Type 2 Diabetes Mellitus
Researcher(s) : -
(Postgraduate Research Grant (PPP) - Research) |
|
end |
Impact Of Pax4 Genes Mutation On Sitagliptin Treatment Response In Type 2 Diabetes Mellitus Patients
(MOSTI-Science Fund) |
|
end |
Clinical And Genetic Markers Of The Dpp Iv Inhibitors Treatment Response In Type 2 Diabetes Mellitus Patients
Researcher(s) : Prof. Dr. Rokiah Binti Pendek
(Geran Penyelidikan Universiti Malaya (UMRG) - HTM (Wellness)) |
|
end |
RESEARCH COLLABORATOR
GRANT | PROGRESS | STATUS |
---|---|---|
Perception, Adherence, Clinical, Economical And Health-related Quality Of Life Outcomes Of Careaide App Usage In Chronic Diseases
Researcher(s) : Prof. Dr. Hasniza Binti Zaman Huri,Dr. Izyan Binti A Wahab,Dr. Kayatri A/p Govindaraju,Dr. Fatiha Hana Shabaruddin,Dr. Nusaibah Binti Abdul Rahim
(Private Funding) |
|
new |
Metabolomics-driven Pharmaceutical Assessment Of Andrographis Paniculata (hempedu Bumi) As Antidiabetic Treatment
Researcher(s) : Dr. Mohd Zuwairi Bin Saiman,Prof. Dr. Hasniza Binti Zaman Huri,David Wishart
(Others MOHE - Top 100 (IIRG)-FNW) |
|
end |
Graphene Based Human Breath Analyzing Sensors For Early Detaction Of Diabetes
Researcher(s) : Dr. Md. Arafat Mahmood,Prof. Dr. Hasniza Binti Zaman Huri,Prof. Dr. Muhammad Yazid Bin Jalaludin,Associate Prof. Dr. Shaifulazuar Bin Rozali,Dusan Losic
(Others MOHE - Top 100 (IIRG)-IISS) |
|
end |
Investigating the role of miR-548m in epithelial-mesenchymal transition of cancer metastasis
Researcher(s) : Prof. Dr. Ivy Chung,Prof. Dr. Hasniza Binti Zaman Huri
(Geran Penyelidikan Universiti Malaya (UMRG) - AFR (Frontier Science)) |
|
end |